Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomas

(2015) Mao-Hua Ding et al.   BIOMATERIALS

AKT2 expression in histopathologic grading and recurrence of meningiomas

(2014) Q. Wang et al.   EJSO

The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML

(2011) J. Zhou et al.   BLOOD

TXNIP (VDUP-1, TBP-2): A major redox regulator commonly suppressed in cancer by epigenetic mechanisms

(2011) Jianbiao Zhou et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Vitamin D3 Upregulated Protein 1 Suppresses TNF- -Induced NF- B Activation in Hepatocarcinogenesis

(2010) H.-J. Kwon et al.   JOURNAL OF IMMUNOLOGY

Medical therapies for meningiomas

(2010) Patrick Y. Wen et al.   JOURNAL OF NEURO-ONCOLOGY

Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells

(2010) Ju-Hee Lee et al.   MOLECULES AND CELLS

CNS complications of radiotherapy and chemotherapy

(2009) Carole Soussain et al.   LANCET